Delivery Order SPE2DB22D6029-SPE2DB24FLTFM
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,804.95 firm fixed-price delivery order is for the supply of 4,567,957,205 units of the medication KINEVAC 5 MCG VIALS. The contract has an ultimate completion date of April 18, 2025 and was awarded on April 17, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held...
This is a delivery order (SPE2DB20D3103|SPE2DB25FN4T3) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,944,134 units of KINEVAC 5 MCG VIALS. The award has a total ceiling value of $4,138.50 and is a firm fixed-price contract with an ultimate completion date of April 17, 2025. The contract is not set aside and was awarded on April 16, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,465.52, is for the supply of KINEVAC 5 MCG VIALS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price type. This delivery order is issued under AmerisourceBergen's larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KINEVAC 5 MCG VIALS, a pharmaceutical product, with a firm fixed price and a ceiling value of $1,823.70. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
The Defense Logistics Agency awarded a $3,013 delivery order to Amerisourcebergen Drug Corporation for 4561585367 Kinevac 5 mcg vials. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from July 24 to July 25, 2023. No set aside designation or subcontractors were...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,615.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the prescription drug KONVOMEP 2-84 MG/ML ORAL SUSP 90ML. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00, which enables the DLA to efficiently procure a wide...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4565005303 MENQUADFI VIAL 0.5ML pharmaceutical products. The firm-fixed-price contract has a ceiling value of $79,447.18 and an ultimate completion date of June 27, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,942.61 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,235,008 vials of the drug Dactinomycin 500 mcg. The contract has a period of performance ending on May 14, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $15,044.88 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of AREXVY VIAL KITS, a critical medical supply, to support military treatment facilities and programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the supply of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific order is...